Literature DB >> 17535859

Early hyponatraemia after pituitary surgery: cerebral salt-wasting syndrome.

R Guerrero1, A Pumar, A Soto, M A Pomares, S Palma, M A Mangas, A Leal, F Villamil.   

Abstract

Hyponatraemia is a common complication in patients undergoing neurosurgery. It can be caused either by the syndrome of inappropriate secretion of antidiuretic hormone or by the cerebral salt-wasting syndrome (CSWS). CSWS frequently occurs in patients suffering from subarachnoid haemorrhage and brain injury, but it is rare after pituitary tumour surgery. However, this diagnostic possibility should be considered as these disorders require specific treatment and have different prognoses. In this article, we present a case of acute and early hyponatraemia caused by CSWS after pituitary tumour surgery. We also revise the aetiology, mechanisms, differential diagnosis and treatment of hyponatraemia after pituitary surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535859     DOI: 10.1530/EJE-06-0659

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  11 in total

1.  Brain natriuretic peptide concentrations after aneurysmal subarachnoid hemorrhage: relationship with hypovolemia and hyponatremia.

Authors:  Sanne M Dorhout Mees; Reinier G Hoff; Gabriel J E Rinkel; Ale Algra; Walter M van den Bergh
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

2.  Cerebral salt wasting syndrome in post-operative pediatric brain tumor patients.

Authors:  Douglas A Hardesty; Todd J Kilbaugh; Phillip B Storm
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

Review 3.  Current best practice in the management of patients after pituitary surgery.

Authors:  Alessandro Prete; Salvatore Maria Corsello; Roberto Salvatori
Journal:  Ther Adv Endocrinol Metab       Date:  2017-03-01       Impact factor: 3.565

4.  Cerebral salt wasting syndrome in a patient affected of spontaneous frontoparietal subdural haematoma.

Authors:  Mariaina Cerdá-Esteve; Mariona Badia; Javier Trujillano; Cecília Vilanova; Javier Maravall; Dídac Mauricio
Journal:  BMJ Case Rep       Date:  2009-10-13

5.  Impact of surgical factors on delayed hyponatremia in patients with nonfunctioning pituitary adenoma after endonasal endoscopic transsphenoidal procedure.

Authors:  Haku Tanaka; Fumihiko Nishimura; Kenta Nakase; Miho Kakutani; Shohei Yokoyama; Takayuki Morimoto; Taekyun Kim; Young-Soo Park; Ichiro Nakagawa; Shuichi Yamada; Kentaro Tamura; Ryosuke Matsuda; Yasuhiro Takeshima; Masashi Kotsugi; Hiroyuki Nakase
Journal:  Endocrine       Date:  2022-08-19       Impact factor: 3.925

6.  A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery.

Authors:  William T Burke; David J Cote; Sherry I Iuliano; Hasan A Zaidi; Edward R Laws
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

7.  Treatment of Hyponatremia with Tolvaptan in a Patient after Neurosurgical Treatment of a Pituitary Tumor: Case Report and Review of Literature.

Authors:  Shinya Ichimura; Rudolf Fahlbusch; Wolf Lüdemann
Journal:  J Neurol Surg Rep       Date:  2015-10-25

8.  Delayed Postoperative Hyponatremia Following Endoscopic Transsphenoidal Surgery for Non-Adenomatous Parasellar Tumors.

Authors:  Hirotaka Hasegawa; Masahiro Shin; Noriko Makita; Yuki Shinya; Kenji Kondo; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2020-12-20       Impact factor: 6.639

9.  Diaphragma sellae sinking can predict the onset of hyponatremia after transsphenoidal surgery for pituitary adenomas.

Authors:  Kunzhe Lin; Jun Li; Lingling Lu; Shangming Zhang; Shuwen Mu; Zhijie Pei; Cheng Wang; Jingying Lin; Liang Xue; Liangfeng Wei; Lin Zhao; Shousen Wang
Journal:  J Endocrinol Invest       Date:  2021-06-14       Impact factor: 4.256

10.  Cerebral salt wasting following tuberculous meningoencephalitis in an infant.

Authors:  Syed Ahmed Zaki; Vijay Lad; Preeti Shanbag
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.